Iodixanol

DRUG17 trials

Sponsors

GE Healthcare, Bracco Diagnostics, Inc, Ospedale San Donato, Norwegian University of Science and Technology, Stanford University

Conditions

Abdominal Aortic AneurysmAcute Myocardial InfarctionChronic Renal DiseaseChronic Renal ImpairmentContrast Induced NephropathyContrast Media ReactionCoronary Artery DiseaseDiabetes Mellitus

Phase 1

Preoperative Embolization of Hypervascular Head and Neck Tumors to Improve Surgical Outcomes

WithdrawnNCT05490381

University of WashingtonMalignant Neoplasm in the Head and Neck, Metastatic Malignant Neoplasm in the Head and Neck

Start: 2023-12-21End: 2025-01-31Updated: 2023-12-12

Phase 3

Safety and Effectiveness of Visipaque 320mg-I/ml for Use in Contrast-Enhanced CT Angiography of Arteries of the Heart

TerminatedNCT00335335

GE HealthcareCoronary Artery Disease

Start: 2006-05-31End: 2006-12-02Updated: 2019-04-25

Safety and Effectiveness of Visipaque 320mg-I/ml for Use in Contrast-Enhanced CT Angiography of Arteries of the Heart

TerminatedNCT00348608

GE HealthcareCoronary Artery Disease

Start: 2006-06-30End: 2006-12-02Updated: 2019-04-25

Phase 4

Renal Safety of Iopamidol Versus Iodixanol During Coronary Angiography in Diabetic Patients

TerminatedNCT00782639

Bracco Diagnostics, IncChronic Renal Impairment, Diabetes Mellitus

Start: 2009-03-31End: 2009-09-30Updated: 2012-01-26

Comparison Between Iso-Osmolar and Ipo-Osmolar Contrast Agents in Patients With Acute Myocardial Infarction (AMI) Undergoing Primary Percutaneous Coronary Intervention (PCI)

CompletedNCT00827788

Ospedale San DonatoAcute Myocardial Infarction, Contrast Induced Nephropathy

Start: 2008-12-31Target: 432Updated: 2010-11-16

Isovue in Peripheral Digital Subtraction Angiography (DSA)

CompletedNCT01075217

Bracco Diagnostics, IncPeripheral Arterial Occlusive Disease

Start: 2010-04-30End: 2011-12-31Updated: 2013-05-30

Iodixanol Versus Iopamidol in Patients Undergoing Contrast-Enhanced Computed Tomographic Imaging of Abdomen/Pelvis

CompletedNCT01376089

GE HealthcarePatient Comfort and Safety

Start: 2011-05-31End: 2012-02-29Updated: 2013-12-19

Nephrotoxicity of Iopamidol Versus Iodixanol in High-Risk Patients

TerminatedNCT01402219

Guangdong Provincial People's HospitalChronic Renal Disease

Start: 2008-11-30End: 2013-05-31Updated: 2013-08-28

Comparing Patient Comfort and Safety Between Iodixanol and Iopamidol in Patients Undergoing Peripheral Arteriography

CompletedNCT01475097

GE HealthcareDrug Safety

Start: 2011-10-31End: 2013-02-28Updated: 2014-06-11

Renal Toxicity of Iodixanol and Iopromide in Patients With Renal Dysfunction

Yong HuoKidney Failure, Chronic

Start: 2012-04-30End: 2013-12-31Target: 200Updated: 2013-10-16

Effects Contrast on Platelet Activity, Thrombosis and Fibrinolysis in Patients Undergoing Coronary Angiography

CompletedNCT01848899

NYU Langone HealthCoronary Artery Disease

Start: 2013-02-28End: 2014-11-30Updated: 2016-04-06

Pediatric Risk of Hypothyroidism With Iodinated Contrast Media

WithdrawnNCT03631771

GE HealthcareHypothyroidism

Start: 2022-03-31End: 2025-02-28Updated: 2022-04-20

Iso-Osmolar vs. Low-Osmolar Contrast Agents for Optical Coherence Tomography

Minneapolis Heart Institute FoundationContrast Media Reaction, Coronary Artery Disease

Start: 2021-09-30End: 2023-06-30Target: 62Updated: 2021-10-25

Unknown Phase

DynaCT in Preoperative Imaging Before Insertion of Stentgraft

CompletedNCT01146639

Norwegian University of Science and TechnologyAbdominal Aortic Aneurysm

Start: 2008-08-31End: 2010-06-30Updated: 2017-01-18

Pulmonary Interstitial Lymphography in Early Stage Lung Cancer

TerminatedNCT01188486

Stanford UniversityLung Cancer, Lung Cancer Non-Small Cell Cancer (NSCLC), Lung Cancer Small Cell Lung Cancer (SCLC) +1

Start: 2010-08-31End: 2017-04-30Updated: 2018-04-17

Prognostic Value of Baseline Computed Tomography (CT) Perfusion Parameters of Pancreatic Cancer for Patients Undergoing Stereotactic Body Radiotherapy or Surgical Resection

TerminatedNCT01326364

Stanford UniversityPancreatic Cancer

Start: 2010-03-31End: 2012-06-30Updated: 2016-07-01

Post-Marketing Safety Study in ST-Segment Elevation Myocardial Infarction (STEMI) Participants Undergoing Primary Percutaneous Coronary Intervention (PCI) Procedure With VISIPAQUE® as the Contrast Medium

CompletedNCT03671603

GE HealthcareCoronary Artery Disease, ST-segment Elevation Myocardial Infarction

Start: 2018-11-05End: 2021-06-07Updated: 2022-01-11